Since October, Zéstine has faced a claim from a competitor; at 31 December, an outflow is considered unlikely and a contingent liability is disclosed. In February, an expert report narrows the range at stake, the outflow remaining unlikely. Which treatment applies?
Single choiceIntermediatePublished